[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![BankTheTrade Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::864584576.png) Palmer [@BankTheTrade](/creator/twitter/BankTheTrade) on x 8961 followers
Created: 2025-07-23 10:32:35 UTC

$ABVX XXXXX up XX announced positive topline results from its Phase X ABTECT-1 (Study 105)        and ABTECT-2 (Study 106) 8-week induction trials evaluating its oral,        first-in-class miR-124 enhancer, obefazimod (ABX464), in adult patients        with moderately to severely active ulcerative colitis (“UC”).


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947968075682246992/c:line.svg)

**Related Topics**
[$abvx](/topic/$abvx)

[Post Link](https://x.com/BankTheTrade/status/1947968075682246992)